• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苔藓抑素1在体外诱导慢性淋巴细胞白血病细胞呈现毛细胞特征。

Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.

作者信息

al-Katib A, Mohammad R M, Dan M, Hussein M E, Akhtar A, Pettit G R, Sensenbrenner L L

机构信息

Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201.

出版信息

Exp Hematol. 1993 Jan;21(1):61-5.

PMID:8093352
Abstract

The phorbol esters induce differentiation of chronic lymphocytic leukemia (CLL) cells. Clinical use of this observation has been hampered by the fact that phorbol esters are also tumor promoters. In this study we demonstrate that another protein kinase C activator, without tumor promoting activity, has similar effects on CLL cells. Fresh leukemic cells from the peripheral blood of 13 patients with CLL were isolated and cultured in the absence (control) or presence of Bryostatin 1 or 12-0-tetradecanoylphorbol 13-acetate (TPA). Aliquots of cells were then analyzed after 24, 72 and 120 hours for morphological changes, acid phosphatase (ACP) and the co-expression of two hairy cell-associated surface antigens, CD22 and CD11c, by flow cytometry. Bryostatin 1 induced changes in shape and morphology similar to TPA, with adherence and increase in cell size, abundant cytoplasm and irregular cytoplasmic membrane. Both agents induced a statistically significant increase in the expression of CD22 and CD11c compared with control (p < 0.0008). There was no significant difference between the two agents in the degree of expression of these two markers. Both agents also induced ACP that was tartrate resistant (TRAP). These changes indicate that Bryostatin is as effective as TPA in inducing further differentiation of CLL cells to a hairy cell stage.

摘要

佛波酯可诱导慢性淋巴细胞白血病(CLL)细胞分化。然而,由于佛波酯也是肿瘤促进剂,这一观察结果在临床上的应用受到了阻碍。在本研究中,我们证明了另一种无肿瘤促进活性的蛋白激酶C激活剂对CLL细胞具有类似的作用。从13例CLL患者外周血中分离新鲜白血病细胞,在无(对照)或有苔藓抑素1或12 - O - 十四烷酰佛波醇13 - 乙酸酯(TPA)的情况下进行培养。然后在24、72和120小时后取细胞 aliquots,通过流式细胞术分析其形态变化、酸性磷酸酶(ACP)以及两种毛细胞相关表面抗原CD22和CD11c的共表达情况。苔藓抑素1诱导的形状和形态变化与TPA相似,表现为细胞贴壁、细胞大小增加、细胞质丰富且细胞质膜不规则。与对照相比,两种药物均诱导CD22和CD11c表达有统计学意义的增加(p < 0.0008)。这两种药物在这两种标志物的表达程度上没有显著差异。两种药物还诱导了抗酒石酸酸性磷酸酶(TRAP)。这些变化表明,苔藓抑素在诱导CLL细胞进一步分化为毛细胞阶段方面与TPA一样有效。

相似文献

1
Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.苔藓抑素1在体外诱导慢性淋巴细胞白血病细胞呈现毛细胞特征。
Exp Hematol. 1993 Jan;21(1):61-5.
2
Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report.用苔藓抑素1序贯治疗一名耐药慢性淋巴细胞白血病患者,随后使用2-氯脱氧腺苷:病例报告。
Clin Cancer Res. 2000 Apr;6(4):1328-32.
3
Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.
Neoplasma. 1995;42(5):221-6.
4
Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.佛波酯体外诱导慢性淋巴细胞白血病细胞出现毛细胞特征
Am J Hematol. 1992 Aug;40(4):264-9. doi: 10.1002/ajh.2830400405.
5
Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro.
Leuk Lymphoma. 1996 Jun;22(1-2):97-101, follow.186, color plate IX. doi: 10.3109/10428199609051734.
6
Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
Eur J Immunol. 1990 May;20(5):1119-23. doi: 10.1002/eji.1830200526.
7
Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.佛波酯诱导B型淋巴细胞白血病出现浆细胞样和毛细胞白血病特征:与B细胞分化和成熟的关系
Blood Cells. 1987;12(2):413-39.
8
Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.苔藓抑素1和2对SH-SY5Y人神经母细胞瘤细胞形态和功能分化的影响。
Cancer Res. 1990 Jun 1;50(11):3422-8.
9
Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.先用苔藓抑素1后用2-氯脱氧腺苷序贯治疗人类慢性淋巴细胞白血病:临床前研究
Clin Cancer Res. 1998 Feb;4(2):445-53.
10
CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.具有介于慢性淋巴细胞白血病和毛细胞白血病之间特征的CD5阳性慢性B细胞白血病。
Hematol Pathol. 1994;8(3):99-109.

引用本文的文献

1
Anticancer Activity of the Marine-Derived Compound Bryostatin 1: Preclinical and Clinical Evaluation.海洋来源化合物苔藓抑素1的抗癌活性:临床前和临床评估
Int J Mol Sci. 2025 Aug 11;26(16):7765. doi: 10.3390/ijms26167765.
2
Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line.苔藓抑素激活 CAR T 细胞抗原非特异性杀伤(CTAK)和 CAR-TNK 样杀伤用于前体 B 细胞急性淋巴细胞白血病,同时阻止 Burkitt 淋巴瘤细胞系的细胞溶解。
Front Immunol. 2022 Feb 9;13:825364. doi: 10.3389/fimmu.2022.825364. eCollection 2022.
3
Functional proteomic analysis reveals roles for PKCδ in regulation of cell survival and cell death: Implications for cancer pathogenesis and therapy.
功能蛋白质组学分析揭示了 PKCδ 在调节细胞存活和细胞死亡中的作用:对癌症发病机制和治疗的影响。
Adv Biol Regul. 2020 Dec;78:100757. doi: 10.1016/j.jbior.2020.100757. Epub 2020 Sep 28.
4
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy.设计的 PKC 调节剂的合成与评价,以增强癌症免疫治疗。
Nat Commun. 2020 Apr 20;11(1):1879. doi: 10.1038/s41467-020-15742-7.
5
Protein kinase C in cellular transformation: a valid target for therapy?细胞转化中的蛋白激酶C:一个有效的治疗靶点?
Biochem Soc Trans. 2014 Dec;42(6):1556-62. doi: 10.1042/BST20140255.
6
The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.岩大戟宁通过上调 CD22 和耗竭 PKC-βII 增强抗 CD22 免疫毒素对 B 细胞淋巴瘤的细胞毒性。
Haematologica. 2012 May;97(5):771-9. doi: 10.3324/haematol.2011.049155. Epub 2011 Dec 16.
7
New drug development in non-Hodgkin lymphomas.
Curr Oncol Rep. 2001 May;3(3):250-9. doi: 10.1007/s11912-001-0058-8.
8
Management of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的管理
Drugs Aging. 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002.
9
Protein kinase C targeting in antineoplastic treatment strategies.抗肿瘤治疗策略中的蛋白激酶C靶向作用
Invest New Drugs. 1999;17(3):227-40. doi: 10.1023/a:1006328303451.
10
Review of survival analyses published in cancer journals.对发表在癌症期刊上的生存分析的综述。
Br J Cancer. 1995 Aug;72(2):511-8. doi: 10.1038/bjc.1995.364.